Has been the dominant variant in Italy and around the world for many weeks omicron 5comes a noveltyIndia where BA.2.75 was sequenced, a subvariant of the existing one that would have an even greater ability to infect. No alarmism, caution: no significant increase in the severity of the disease or in mortality has been detected, it is just the natural “evolution” of Sars-CoV-2, which is always destined to change.
prof. Matteo Bassetti he commented on the subject: see below Twitter wrote that what has been noted in India and other countries is worth “keeping in mind”. “# Ba.2.75 could be even more contagious than 5 and have a high contagious capacity for healed and vaccinated people. eye without alarm,” he emphasizes. One of the first to speak about it was Prof. Thomas Pfau, a scientist from Imperial College London, who called it a “second-generation variant” due to the numerous mutations in the spike protein, the key to the virus’ entry into our organism. As reported by Indian media, the sub-variant BA.2.75 is also spreading to the USA, Canada and Japan. However, in Indian territory, some cases have been reported in the regions of Maharashtra, Karnataka and Jammu and Kashmir.
“No changes needed”
“In that sentence Not there is proof that BA.2.75 requires a change in pre-existing public health settings to handle other variants of Omicron, “experts from India and New Zealand know where some cases have been sequenced. As we have often discussed and argued, the experts remember this variant always has a different name: it was from Alpha to Omicron.If it is a subvariant then there is nothing to worry about since they are small mutations such as not to cause concern and not having to change the name Therefore, there is nothing important to worry about at this stage.
The study of the BA.2.75
“Currently there is no evidence that BA.2.75 also causes a more severe form of the infection,” said Dr. Rajesh Karya card, Microbiologist at BJ Medical College in Pune, India and Head of Genome Sequencing in Maharashtr, State of India. New clinical studies are being prepared to assess the impact of this mutation on the human organism. The only difference from the current Omicron is that “it is possible that mutations in subvariant BA.2.75 give it a greater ability to evade antibodies and attach to human cells increase of infectivity even in those previously infected or fully vaccinated”.